150 related articles for article (PubMed ID: 1871934)
1. [Carcinoma in situ of the urinary bladder--definition and status of treatment].
Otto T; Rübben H
Urologe A; 1991 May; 30(3):163-6. PubMed ID: 1871934
[TBL] [Abstract][Full Text] [Related]
2. Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Guérin.
Palou J; Sylvester RJ; Faba OR; Parada R; Peña JA; Algaba F; Villavicencio H
Eur Urol; 2012 Jul; 62(1):118-25. PubMed ID: 22101115
[TBL] [Abstract][Full Text] [Related]
3. [Clinical observation of 8 cases of carcinoma in situ of the urinary bladder].
Murase T; Ito H; Ohishi M; Takashi M
Hinyokika Kiyo; 1989 Apr; 35(4):583-5. PubMed ID: 2735263
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoma in situ of the bladder involving the prostate with an unusual invasive pattern following BCG therapy: a case report].
Iba A; Kohjimoto Y; Inagaki T; Suzuki A; Fujii R; Senzaki H; Uekado Y; Shinka T
Hinyokika Kiyo; 2005 Oct; 51(10):681-4. PubMed ID: 16285623
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy.
Ajili F; Kourda N; Darouiche A; Chebil M; Boubaker S
Ultrastruct Pathol; 2013 Feb; 37(1):56-61. PubMed ID: 23383616
[TBL] [Abstract][Full Text] [Related]
6. Assessing treatment response after induction Bacillus Calmette-Guerin for carcinoma in situ of the urinary bladder: can post-induction random bladder biopsies be avoided?
Smith PJ; Lotan Y; Raj GV; Sagalowsky AI; Margulis V
Cytopathology; 2014 Apr; 25(2):108-11. PubMed ID: 23551700
[TBL] [Abstract][Full Text] [Related]
7. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
8. Intravesical therapy for superficial bladder cancer.
Malkowicz SB
Semin Urol Oncol; 2000 Nov; 18(4):280-8. PubMed ID: 11101091
[TBL] [Abstract][Full Text] [Related]
9. Carcinoma in situ.
Lamm DL
Urol Clin North Am; 1992 Aug; 19(3):499-508. PubMed ID: 1636234
[TBL] [Abstract][Full Text] [Related]
10. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment].
Higashi S; Matsui Y; Takahashi T; Nishiyama H; Ito N; Yamamoto S; Kamoto T; Ogawa O
Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268
[TBL] [Abstract][Full Text] [Related]
11. [Management of Ta, T1, and in situ bladder carcinoma: what is new?].
Irani J
Prog Urol; 2008 May; 18 Suppl 5():S94-8. PubMed ID: 18585634
[TBL] [Abstract][Full Text] [Related]
12. [Intravesical immunotherapy of in situ carcinoma of the urinary bladder using Bacillus Calmette-Guerin (BCG)].
Jakse G
Wien Klin Wochenschr; 1987 Feb; 99(4):114-8. PubMed ID: 3577186
[TBL] [Abstract][Full Text] [Related]
13. Superficial urinary bladder cancer. Results from the Finnbladder studies and a review on instillation treatments.
Jauhiainen K; Rintala E
Ann Chir Gynaecol Suppl; 1993; 206():31-8. PubMed ID: 8291866
[TBL] [Abstract][Full Text] [Related]
14. When is a cystectomy necessary in carcinoma in situ?
Herr HW
Prog Clin Biol Res; 1989; 303():511-5. PubMed ID: 2780659
[No Abstract] [Full Text] [Related]
15. In situ transitional cell carcinoma involvement of prostatic urethra: bacillus Calmette-Guérin therapy without previous transurethral resection of the prostate.
Palou J; Xavier B; Laguna P; Montlleó M; Vicente J
Urology; 1996 Apr; 47(4):482-4. PubMed ID: 8638354
[TBL] [Abstract][Full Text] [Related]
16. Intravesical therapy for bladder cancer.
Williams SK; Hoenig DM; Ghavamian R; Soloway M
Expert Opin Pharmacother; 2010 Apr; 11(6):947-58. PubMed ID: 20205607
[TBL] [Abstract][Full Text] [Related]
17. When intravesical measures fail. Indications for cystectomy in superficial disease.
Hudson MA
Urol Clin North Am; 1992 Aug; 19(3):601-9. PubMed ID: 1636242
[TBL] [Abstract][Full Text] [Related]
18. [Case of tuberculous epididymitis caused by intravesical BCG therapy].
Koizumi T; Nakanishi R; Taue R; Yamaguchi K; Nakatuji H; Kishimoto T; Izaki H; Oka N; Takahashi M; Fukumori T; Kanayama HO
Hinyokika Kiyo; 2008 Sep; 54(9):625-7. PubMed ID: 18975579
[TBL] [Abstract][Full Text] [Related]
19. Principles of intravesical chemotherapy and immunotherapy.
Sarosdy MF
Urol Clin North Am; 1992 Aug; 19(3):509-19. PubMed ID: 1636235
[TBL] [Abstract][Full Text] [Related]
20. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H
Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]